| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |